CoChat

Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma

Open access
Gao, Ying, Katki, Hormuzd, Graubard, Barry, Pollak, Michael, Martin, Michael, Tao, Yuzhen, Schoen, Robert E., Church, Timothy, Hayes, Richard B., Greene, Mark H., Berndt, Sonja I. · 2012 · International Journal of Cancer
Cited by 59

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

The insulin‐like growth factor (IGF) signaling pathway is involved in cell proliferation and differentiation. Elevated serum IGF1 levels have been associated with increased colorectal cancer risk; however, studies of this association with colorectal adenoma are inconclusive. We examined serum IGF1, IGF2 and IGFBP3 levels in relation to risk of advanced colorectal adenoma in a case‐control study within the prostate, lung, colorectal and ovarian cancer screening trial. A total of 764 advanced, left‐sided colorectal adenoma cases and 775 controls frequency‐matched on gender and ethnicity, without evidence of a left‐sided polyp on sigmoidoscopy were included in the current study. Serum levels of IGF1, IGF2 and IGFBP3 were measured using an enzyme linked immunosorbent assay in serum samples collected at baseline. Logistic regression was used to estimate the odds ratios (OR) and 95% confidence intervals (CI) for the associations adjusting for age, race, sex, year of blood draw, body mass index, smoking and education. Higher IGF1 levels were associated with increased adenoma risk: ORs = 1.58 (95% CI = 1.16–2.16), 1.42 (95% CI = 1.04–1.93), and 1.80 (95% CI = 1.30–2.47) for the second, third and fourth quartiles, respectively (ptrend = 0.002). Elevated IGF2 levels were also associated with increased adenoma risk (OR = 1.43, 95% CI = 1.05–1.96 for the fourth vs. first quartile, ptrend = 0.02), but the association was no longer significant after adjustment for IGF1 (ptrend = 0.28). IGFBP3 levels were not associated with adenoma risk. Our analysis showed a significant positive association between circulating IGF1 levels and risk of advanced colorectal adenoma, suggesting that IGF1 is associated with the pivotal precursor to colorectal cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ijc.26438

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

Metadata

Authors
Gao, Y., Katki, H., Graubard, B., Pollak, M., Martin, M., Tao, Y., Schoen, R. E., Church, T., Hayes, R. B., Greene, M. H., & Berndt, S. I.
Venue
International Journal of Cancer
Publisher
Wiley
Published
2011-11-02
Volume
131
Issue
2
Pages
E105-13
ISSN
  • 0020-7136 (ISSN-L)
  • 1097-0215
OpenAlex
W2151646894
Cited by
59
References
1
FWCI
4.00
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.